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Summary
For mammalian somatic cells, the importance of mi-
crotubule cytoskeleton integrity during interphase
cell-cycle progression is uncertain. The loss, suppres-
sion, or stabilization of the microtubule cytoskeleton
has beenwidely reported to cause a G1 arrest in a vari-
able, and often high, proportion of cell populations,
suggesting the existence of a ‘‘microtubule damage,’’
‘‘microtubule integrity,’’ or ‘‘postmitotic’’ checkpoint
in G1 or G2 [1–7]. We found that when normal human
cells (hTERTRPE1 and primary fibroblasts) are contin-
uously exposed to nocodazole, they remain in mitosis
for 10–48 hr before they slip out ofmitosis and arrest in
G1; this finding is consistent with previous reports [2,
4, 6]. To eliminate the persistent effects of prolonged
mitosis, we isolated anaphase-telophase cells that
were just finishing a mitosis of normal duration, then
we rapidly and completely disassembledmicrotubules
by chilling the preparations to 0C for 10minutes in the
continuous presence of nocodazole or colcemid treat-
ment to ensure that the cells entered G1 without a mi-
crotubule cytoskeleton. Without microtubules, cells
progressed from anaphase to a subsequent mitosis
with essentially normal kinetics. Similar results were
obtained for cells in which the microtubule cytoskele-
ton was partially diminished by lower nocodazole
doses or augmented and stabilized with taxol. Thus,
after a precedingmitosis of normal duration, the integ-
rity of the microtubule cytoskeleton is not subject to
checkpoint surveillance, nor is it required for the nor-
mal human cell to progress through G1 and the re-
mainder of interphase.
Results and Discussion
The mammalian somatic cell in early G1 is sensitive to
a number of intracellular and extracellular stimuli; the in-
tegration of growth-promoting and growth-inhibiting in-
puts determines whether the cell will commit to entering
the cell cycle [8–12]. The integrity of the actin cytoskele-
ton is important to the cell’s ability to enter S phase.
Even a slight perturbation of the actin cytoskeleton
with cytochalasin leads to a durable G1 arrest [13–20].
Because the interphase array of microtubules, focused
on the centrosome, is necessary for a variety of impor-
tant cellular processes, its integrity could be necessary
for the cell to progress through G1, as is the case for
the actin cytoskeleton. In this regard, at least 27 studies
*Correspondence: greenfield.sluder@umassmed.edu(Tables S1–S3 in the Supplemental Data available on-
line) contain data regarding the impact of microtubule
cytoskeleton alteration on G1 progression for a variety
of mammalian cell lines. Almost all report that alterations
of the microtubule cytoskeleton lead to a G1 arrest in
a variable and often high proportion of the cell popula-
tions, particularly for cell lines expected to have an intact
p53 pathway. However, cells within a population typi-
cally respond to microtubule perturbation in a nonuni-
form manner; a variable portion of the cells progress
past G1 in the absence of microtubules. Of note are
three studies that report substantial G1 progression in
p53-normal cells with a partially or completely disas-
sembled microtubule array (Table S1, lines highlighted
in gray). The varied results of these studies prompted
us to directly examine whether and how perturbation
of the microtubule cytoskeleton influences G1 progres-
sion in normal human cells. This issue is of interest be-
cause a number of microtubule-targeting drugs are cur-
rently used as chemotherapeutic agents for human
cancer patients (reviewed in [21, 22]).
We used primary human fibroblasts and hTERT RPE1
cells, which are normal human cells immortalized by the
expression of the reverse-transcriptase subunit of telo-
merase. These cells have an intact p53 pathway, as evi-
denced by cell-cycle arrest, with elevated levels of p21
in response to DNA damage (data not shown). We har-
vested mitotic cells from asynchronous populations by
a gentle shake-off procedure (Figures 1A and 1F) to ob-
tain cells in mitotic stages ranging from prometaphase
to telophase (Figures 1B and 1G). Within 3 min the cells
were exposed to 1.6–3.2 mM nocodazole or 1 mM colce-
mid and then chilled to 0C. This caused the immediate
and complete disassembly of spindle microtubules (Fig-
ures 1C and S1A). For anaphase-telophase cells, no sta-
ble microtubules were seen in the region between the
separated chromosomes after cold treatment in the
presence of nocodazole (Figures 1C and S1A). This
rapid and persistent disassembly of microtubules was
important because it ensured that the cells did not later
enter G1with a partial but declining microtubule cyto-
skeleton that could, in principle, support some measure
of G1 progression. After 10 min of cold, the population
was plated out on coverslips and warmed to 37C in
the continued presence of microtubule inhibitor. The
prometaphase cells remained arrested in mitosis be-
cause of the activity of the spindle-assembly checkpoint,
whereas those in anaphase-telophase completed mito-
sis within about 30 min, flattened out, and attached to
the coverslip (Figure 1D). Cleavage failed in roughly 2/
3 of the cases. Approximately 1 hr after the cells were re-
plated, we washed the coverslips to remove the round,
nonadherent prometaphase cells and added BrdU to
the medium. This protocol allowed us to obtain a popu-
lation of initially anaphase-telophase cells that com-
pleted mitosis and later entered G1 in the complete
absence of microtubules. Three hours after shake off
these cells contained no microtubules (Figure 1E),
Current Biology Vol 17 No 23
2082indicating a persistent microtubule knockdown. We later
fixed some coverslips to assay for BrdU incorporation,
and we continuously followed individual cells on other
coverslips with video time-lapse microscopy to deter-
mine whether and when they entered the next mitosis.
Control experiments were conducted in the same
fashion, except that no microtubule inhibitor was added.
We found that control cells rapidly reassembled spindles
within 5–10 min of rewarming after the cold treatment, di-
vided in a normal fashion within 1 hr, and flattened out as
they entered G1 (Figures 1H and 1I). Three hours after
shake off all cells contained a normal interphase array
of microtubules (Figure 1J). By 18 hr, 94% had entered
S phase as determined by BrdU incorporation, and all
34 individually followed cells entered mitosis within 28
hr. Interphase duration averaged 21 hr (Figure 2, top line).
When one evaluates interphase progression without
a microtubule cytoskeleton, it is important to differenti-
ate between drug-treated cells that slip out of a pro-
longed mitosis into G1 and cells that lose their microtu-
bules at the end of a normal mitosis. Thus, we first
followed interphase progression for the cells slipping
out of grossly prolonged mitosis. Prometaphase cells
that were washed off the coverslips after chilling were
continuously followed via time-lapse video microscopy
in the presence of microtubule inhibitors and BrdU. Wefound that both RPE1 and primary fibroblasts remained
in mitosis for 10–48 hr before they slipped into G1 as un-
divided mononucleated cells [23]. Observations carried
out to 100 hr revealed that such cells did not progress
into mitosis. None of the cells showed incorporation of
BrdU at 24, 48, or 72 hr (n > 200 at each time point), in-
dicating a G1 arrest, which is consistent with previous
reports [2, 4, 6]. This arrest is not due to the lack of cyto-
kinesis, because normal human cells do not have a tetra-
ploidy checkpoint [33]. In the continuous presence of
microtubule inhibitors, cells arrest in G1 after prolonged
mitosis.
Next we examined interphase progression without
a microtubule cytoskeleton, this time after a mitosis
of normal duration. Nocodazole- or colcemid-treated
RPE1cells that were initially in anaphase-telophase
were assayed for BrdU incorporation at 18, 24, and
30 hr after shake off (Figure 2, lines 2 and 3). Eighty-
five percent showed BrdU incorporation by 18 hr and
slightly higher rates at 24 and 30 hr. Long-term video
time-lapse observations (Figure 2, top line of images;
also Movie S1) revealed that such cells became exten-
sively flattened during interphase and later entered
a subsequent mitosis. By 36 hr after the shake off 95%
(82/86) of the nocodazole-treated cells and 100%
(35/35) of the colcemid-treated cells entered mitosis,Figure 1. Collecting Anaphase-Telophase Cells and Microtubule Disassembly
(A–E) Experimental cells. Culture of freely cycling RPE1 cells (A). Cells shaken off such cultures, chilled to 0C for 10 min, and treated with mi-
crotubule inhibitor (B). Representative mitotic cells fixed immediately after being rewarmed in the presence of 1.6–3.2 mM nocodazole (or 1 mM
colcemid) (C). Upper panels: Immunostaining for alpha tubulin reveals that no microtubules are present. Lower panels: chromosome distribution
in the same cells (Hoechst label). One hour after shake off: Anaphase-telophase cells finish mitosis and begin to spread out on the coverslip. Cells
arrested in prometaphase are still round and non-adherent (D). A cell fixed for alpha tubulin immunofluorescence 3 hr after shake off. No micro-
tubules are present. This cell failed cleavage and is thus binucleate (E).
(F–J) Control cells. Culture before shake off of mitotic cells (F). Cells shaken off such cultures and chilled to 0C for 10 min (G). Representative
mitotic cells fixed 10 min after being rewarmed (H). Upper panels: Immunostaining for alpha tubulin reveals reassembly of normal spindles. Lower
panels: chromosome distribution in the same cells (Hoechst label). Cells 1 hr after shake off: All cells finish mitosis and begin to spread out on the
coverslip (I). Normal interphase microtubule cytoskeleton in a cell fixed for alpha-tubulin immunofluorescence 3 hr after shake off. Phase-
contrast and fluorescence microscopy (J). Scale bars represent 20 mm.
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2083where they arrested because of the spindle-assembly
checkpoint. Ten to 48 hr later the cells slipped out of this
mitosis and entered interphase; a few cells died during
the prolonged mitosis. Progression through interphase
for cells without microtubules proceeded, on average,
with normal kinetics (Figure 2, ‘‘Duration of interphase’’).
The average length of time between shake off and sub-
sequent mitosis was 21 hr for the control cells, 22 hr for
the nocodazole-treated populations, and 20 hr for the
colcemid-treated cells.
To test whether these results reflect an unexpected
peculiarity of hTERT RPE1 cells, we conducted the
same experiments with primary human fibroblasts. As
shown in Figure 2 (line 5), 81% of these cells showed
BrdU incorporation by 18 hr, and 96% showed incorpo-
ration by 30 hr. By 36 hr 88% had entered mitosis, and
their interphase duration was, on average, 4 hr longer
than that of the controls (Figure 2, line 4 versus line 5).
The bottom line of images in Figure 2 shows a primary
fibroblast flattening out at the end of mitosis and pro-
gressing to the next mitosis in the complete absence
of a microtubule cytoskeleton.Next we used RPE1 cells to test whether partial dis-
ruption of microtubules influences cell-cycle progres-
sion through G1. These experiments were motivated
by the possibility that cells might be able to sense the
presence of a dysfunctional microtubule array even
though they cannot sense its complete absence. We
conducted the same experiments with 0.1–0.8 mM noco-
dazole (versus 1.6–3.2 mM previously used). As shown in
Figure 3 (first four images), these cells completed
mitosis and assembled partial interphase microtubule
cytoskeletons whose size was inversely proportional
to nocodazole concentration. We found that 90%–92%
of these cells incorporated BrdU by 18 hr, irrespective
of the nocodazole concentration used (Figure 3, top
four lines). By 36 hr 93%–96% of the cells had entered
mitosis; such percentages are comparable to those
observed for cells without a microtubule cytoskeleton
(Figure 3, top four lines). Average interphase durations
ranged from 21–23 hr and did not depend on nocodazole
concentration.
To test whether the stabilization of the microtubule
cytoskeleton influences the ability of cells to progressFigure 2. Interphase Cell-Cycle Progression of RPE1 and Primary Human Fibroblast Cells without a Microtubule Cytoskeleton
Upper portion shows the percentage of BrdU incorporation at the indicated times and the proportion of cells entering mitosis. The ‘‘duration of
interphase’’ (mean,6 the standard deviation) is the time from shake off to the rounding up at subsequent mitosis for cells continuously followed
by time-lapse video microscopy. First row of images: RPE1 cell progressing from telophase to mitosis without a microtubule cytoskeleton. This
cell failed to cleave and was consequently binucleate. Images were taken from Movie S1. Lower row of images: Primary human fibroblast
progressing from telophase to mitosis without a microtubule cytoskeleton. This cell failed to cleave and was consequently binucleate.
Phase-contrast microscopy; time (hours:minutes) recorded since replating of the cells is shown in the lower corner of each frame. The scale
bar represents 20 mm.
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10 or 100 nM paclitaxel (taxol) without exposing the cells
to cold. These taxol doses led to a pronounced augmen-
tation of the interphase microtubule array (Figure 3, last
image). These doses should also disrupt microtubule-tip
dynamics because even 1 nM taxol is sufficient to acti-
vate the spindle-assembly checkpoint in RPE1 cells
(data not shown). At 18 hr after shake off, 87% of the
cells treated with 10 nM taxol and 88% of those treated
with 100 nM taxol showed BrdU incorporation (Figure 3,
lines 5 and 6). Eighty-five to eighty-nine percent of the
cells entered mitosis with normal kinetics. Similar results
were obtained with primary human fibroblasts (Figure 3,
lowest line).
Together, our results reveal that the ability of normal
human cells to progress through G1 and the remainder
of interphase with an altered or disassembled microtu-
bule cytoskeleton critically depends upon whether the
preceding mitosis was of prolonged or normal duration.
When mitosis is prolonged by >10 hr, cells arrest in the
following G1 in a p53-dependent fashion whether or
not the microtubule inhibitor is washed out before slip-
page into interphase (this study and [2, 4, 6, 27, 28]).
This G1 arrest may be the consequence of the formation
of DNA breaks during or just after prolonged mitosis [29]
and/or the accumulation of p53 during an extendedmitosis [30, 31]. However, when the microtubule cyto-
skeleton is completely disassembled during anaphase
or telophase of a normal mitosis, the cells proceed
through G1 and on to the subsequent mitosis with
essentially normal kinetics. Thus, the presence of a
microtubule cytoskeleton is not required for a cell to
commit during G1 to enter the cell cycle, and there is
no indication of a ‘‘microtubule damage checkpoint’’
or a microtubule-dependent ‘‘post-mitotic checkpoint’’
operating during G1 or G2 as previously proposed
[1–7]. We note, however, that a small percentage of
both RPE1 and primary human fibroblasts, whose
microtubule cytoskeleton is disassembled, are slower
than the controls and the majority of their cohorts to
advance into S phase. We speculate that this could
indicate that loss of microtubules is a stress for cells
and acts additively with stresses found under normal
culture conditions to slow but not stop G1 in a minority
of the experimental cells. For the vast majority of the
cells in our study, the stress of microtubule loss is not
one of sufficient strength to slow the cell cycle. In princi-
ple, consideration of stress could provide an explana-
tion for why many investigators observe a G1 arrest in
a proportion of cells when their microtubule cytoskele-
tons are disassembled (Table S1). Stresses inherent in
synchronization protocols, such as serum starvation orFigure 3. Cell-Cycle Progression of RPE1 and Primary Human Fibroblasts in which the Microtubule Cytoskeleton Has Been Diminished or
Augmented by 0.1–0.8 mM Nocodazole or 10–100 nM Taxol, Respectively
Upper portion shows the percentage of BrdU incorporation at 18 hr and the proportion of RPE1 cells or primary human fibroblasts entering a sub-
sequent mitosis. The duration of interphase (mean,6 the standard deviation) is the time from shake off to the rounding up at subsequent mitosis
for cells continuously followed by time-lapse video microscopy. The images show the extent of the diminishment or augmentation of the micro-
tubule cytoskeleton in RPE1 cells that were continuously exposed to the indicated drugs and drug concentrations. The cells were fixed at 3 hr
after shake off and immunostained for alpha-tubulin. Fluorescence microscopy: The scale bar represents 20 mm.
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2085side effects of high microtubule inhibitor doses, could in
principle work additively with microtubule loss to cause
a p53-dependent G1 arrest. The notion that disassembly
of the microtubule cytoskeleton stresses the cell is con-
sistent with the finding that microtubule disassembly in
early prophase causes transient return to interphase [24]
in a p38 stress-activated kinase-dependent fashion [25].
That said, we note that we did not observe a systematic
prolongation of interphase as might be predicted by
these studies. We speculate that cells already progress-
ing through interphase without a microtubule cytoskele-
ton have accommodated to the stress of microtubule
loss and thus do not delay entry into mitosis. Another
indication that microtubule loss can be a stress comes
from our observations that, although centrosome re-
moval from RPE1 cells does not impede G1 progression
[26], exposure of such acentrosomal cells to 1.6 mM
nocodazole to disassemble microtubules causes a G1
arrest in all six cells examined (Y.U. and G.S., unpub-
lished data).
We also found that normal human cells do not detect
the presence of a diminished or stabilized microtubule
cytoskeleton after mitosis of normal duration, as indi-
cated by most previous studies (Table S1). This argues
against the formal possibility that complete loss of the
microtubule cytoskeleton eliminates structural compo-
nents or microtubule-dependent interactions that are
necessary for the cell to sense a dysfunctional microtu-
bule cytoskeleton. In addition, our results indicate that
the loss or alteration of the microtubule cytoskeleton
does not functionally impact the actin cytoskeleton in
a way that triggers a G1 arrest, such as that observed
for low doses of cytochalasin [13–20].
In summary, our results demonstrate that the normal
human cell does not have a checkpoint mechanism
that detects the loss, diminishment, or augmentation
of the interphase microtubule cytoskeleton during G1
as long as the preceding mitosis was of normal duration.
Under our experimental conditions, cells can proceed
through one entire cell cycle without a microtubule cyto-
skeleton; they progress from the end of mitosis through
interphase into mitosis and eventually slip out of mitosis
into G1. Drugs that destabilize or stabilize microtubules
are used for chemotherapy in the treatment of a number
of human tumors (reviewed in [21, 22]). Although the way
in which these drugs lead to the killing of cells is not fully
understood, recent studies on cancer cell lines indicate
that these drugs promote apoptosis during prolonged
mitosis and/or during subsequent G1 arrest (reviewed
in [32]). Our results suggest that the G1 killing of cancer
cells by drugs that stabilize or destabilize microtubules
is not due to dysfunction of the microtubule cytoskele-
ton per se during G1. Rather, the killing may be linked
to G1 arrest following slippage through a grossly pro-
longed mitosis.
Experimental Procedures
Cell Culture, Drug Treatments, and Immunofluorescence
HTERT-RPE1 cells were obtained from CLONTECH Laboratories,
and human primary foreskin fibroblasts (BJ strain) were obtained
from American Type Culture Collection (Manassas, VA). Cells were
cultured as described in [33]. Nocodazole, colcemid, and paclitaxel
(taxol) were purchased from Sigma-Aldrich and used at the indi-
cated concentrations (one part DMSO stock per 2000 partsmedium). For collecting mitotic cells from freely cycling populations,
plates were shaken and medium was gently pipetted across the sur-
face of the culture dish. Within 3 min the cells were exposed to no-
codazole or colcemid in test tubes, and the tubes were inserted
into wet ice (0C) for 10 min. During the taxol experiments, the cells
were exposed to the drug in test tubes without chilling.
Cells were plated on 22 mm coverslips and warmed to 37C in
a CO2 incubator. One hour after the cells were replated, the round,
nonadherent prometaphase cells were washed off, and the cells
that spread out on the coverslips were cultured with media contain-
ing microtubule inhibitors and BrdU (5 mg/ml). The round prometa-
phase cells in the media were placed in a new culture dish with
new coverslips and cultured with media containing the microtubule
inhibitors and BrdU (5 mg/ml). Coverslips bearing cells were cultured
in a CO2 incubator and later fixed for BrdU analysis; other coverslips
were mounted in observation chambers for continuous time-lapse
video analysis. So that efficacy of the microtubule inhibitors could
be assayed, cells on some coverslips were fixed in cold methanol
and processed for indirect immunofluorescence with monoclonal
alpha-tubulin antibody (Sigma-Aldrich), Alexa Fluor 488 goat anti-
mouse secondary antibody (Molecular Probes), and Hoechst 33258
[34]. BrdU incorporation was determined as previously described
[33]. Observations were made with a Leica DMR-series microscope
equipped for phase contrast and fluorescence.
Time-Lapse Video Analysis
Coverslips bearing cells were assembled into chambers [35] con-
taining nocodazole, colcemid, or taxol at the indicated concentra-
tions. Individual cells were followed at 37C with Zeiss Universal
(Carl Zeiss MicroImaging) or Olympus BH-2 (Olympus) microscopes
equipped with phase-contrast optics. Images were recorded with
Orca ER, Orca 100 (Hamamatsu), Retiga EX, and/or Retiga EXi cam-
eras (Qimaging); sequences were written to the hard drives of PC
computers via Simple PCI software (Compix Imaging Systems, divi-
sion of Hamamatsu) and were exported as AVI movies.
Supplemental Data
Three tables, one figure, and one movie are available at http://www.
current-biology.com/cgi/content/full/17/23/2081/DC1/.
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